Share-based Payment Arrangement, Expense of PACIFIC BIOSCIENCES OF CALIFORNIA, INC. from 31 Dec 2011 to 30 Sep 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2011 to 30 Sep 2024.
  • PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2024 was $18,259,000, a 7.3% decline year-over-year.
  • PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2024 was $71,587,000, a 2.6% decline year-over-year.
  • PACIFIC BIOSCIENCES OF CALIFORNIA, INC. annual Share-based Payment Arrangement, Expense for 2023 was $72,118,000, a 8.3% decline from 2022.
  • PACIFIC BIOSCIENCES OF CALIFORNIA, INC. annual Share-based Payment Arrangement, Expense for 2022 was $78,613,000, a 2.6% decline from 2021.
  • PACIFIC BIOSCIENCES OF CALIFORNIA, INC. annual Share-based Payment Arrangement, Expense for 2021 was $80,728,000, a 360% increase from 2020.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $71,587,000 $18,259,000 -$1,432,000 -7.3% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $73,019,000 $17,219,000 -$672,000 -3.8% 01 Apr 2024 30 Jun 2024 10-Q 09 Aug 2024 2024 Q2
Q1 2024 $73,691,000 $19,525,000 +$1,573,000 +8.8% 01 Jan 2024 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $72,118,000 $16,584,000 -$1,371,000 -7.6% 01 Oct 2023 31 Dec 2023 10-K 28 Feb 2024 2023 FY
Q3 2023 $73,489,000 $19,691,000 +$755,000 +4% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 $72,734,000 $17,891,000 -$1,128,000 -5.9% 01 Apr 2023 30 Jun 2023 10-Q 09 Aug 2024 2024 Q2
Q1 2023 $73,862,000 $17,952,000 -$4,751,000 -21% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q4 2022 $78,613,000 $17,955,000 -$983,000 -5.2% 01 Oct 2022 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q3 2022 $79,596,000 $18,936,000 -$16,884,000 -47% 01 Jul 2022 30 Sep 2022 10-Q 03 Nov 2023 2023 Q3
Q2 2022 $96,480,000 $19,019,000 +$3,214,000 +20% 01 Apr 2022 30 Jun 2022 10-Q 04 Aug 2023 2023 Q2
Q1 2022 $93,266,000 $22,703,000 +$12,538,000 +123% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q4 2021 $80,728,000 $18,938,000 +$13,663,000 +259% 01 Oct 2021 31 Dec 2021 10-K 28 Feb 2024 2023 FY
Q3 2021 $67,065,000 $35,820,000 +$30,828,000 +618% 01 Jul 2021 30 Sep 2021 10-Q 05 Nov 2021 2021 Q3
Q2 2021 $36,237,000 $15,805,000 +$12,571,000 +389% 01 Apr 2021 30 Jun 2021 10-Q 08 Aug 2022 2022 Q2
Q1 2021 $23,666,000 $10,165,000 +$6,133,000 +152% 01 Jan 2021 31 Mar 2021 10-Q 06 May 2022 2022 Q1
Q4 2020 $17,533,000 $5,275,000 +$1,406,000 +36% 01 Oct 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
Q3 2020 $16,127,000 $4,992,000 +$930,000 +23% 01 Jul 2020 30 Sep 2020 10-Q 05 Nov 2021 2021 Q3
Q2 2020 $15,197,000 $3,234,000 -$855,000 -21% 01 Apr 2020 30 Jun 2020 10-Q 06 Aug 2021 2021 Q2
Q1 2020 $16,052,000 $4,032,000 -$349,000 -8% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021 2021 Q1
Q4 2019 $16,401,000 $3,869,000 -$3,653,000 -49% 01 Oct 2019 31 Dec 2019 10-K 28 Feb 2022 2021 FY
Q3 2019 $20,054,000 $4,062,000 -$1,063,000 -21% 01 Jul 2019 30 Sep 2019 10-Q 03 Nov 2020 2020 Q3
Q2 2019 $21,117,000 $4,089,000 -$1,135,000 -22% 01 Apr 2019 30 Jun 2019 10-Q 06 Aug 2020 2020 Q2
Q1 2019 $22,252,000 $4,381,000 -$901,000 -17% 01 Jan 2019 31 Mar 2019 10-Q 08 May 2020 2020 Q1
Q4 2018 $23,153,000 $7,522,000 +$2,131,000 +40% 01 Oct 2018 31 Dec 2018 10-K 26 Feb 2021 2020 FY
Q3 2018 $21,022,000 $5,125,000 +$157,000 +3.2% 01 Jul 2018 30 Sep 2018 10-Q 07 Nov 2019 2019 Q3
Q2 2018 $20,865,000 $5,224,000 +$215,000 +4.3% 01 Apr 2018 30 Jun 2018 10-Q 06 Aug 2019 2019 Q2
Q1 2018 $20,650,000 $5,282,000 +$298,000 +6% 01 Jan 2018 31 Mar 2018 10-Q 03 May 2019 2019 Q1
Q4 2017 $20,352,000 $5,391,000 +$555,000 +11% 01 Oct 2017 31 Dec 2017 10-K 28 Feb 2020 2019 FY
Q3 2017 $19,797,000 $4,968,000 -$139,000 -2.7% 01 Jul 2017 30 Sep 2017 10-Q 05 Nov 2018 2018 Q3
Q2 2017 $19,936,000 $5,009,000 -$29,000 -0.58% 01 Apr 2017 30 Jun 2017 10-Q 03 Aug 2018 2018 Q2
Q1 2017 $19,965,000 $4,984,000 +$403,000 +8.8% 01 Jan 2017 31 Mar 2017 10-Q 02 May 2018 2018 Q1
Q4 2016 $19,562,000 $4,836,000 +$809,000 +20% 01 Oct 2016 31 Dec 2016 10-K 26 Feb 2019 2018 FY
Q3 2016 $18,753,000 $5,107,000 +$1,869,000 +58% 01 Jul 2016 30 Sep 2016 10-Q 02 Nov 2017 2017 Q3
Q2 2016 $16,884,000 $5,038,000 +$1,718,000 +52% 01 Apr 2016 30 Jun 2016 10-Q 02 Aug 2017 2017 Q2
Q1 2016 $15,166,000 $4,581,000 +$1,326,000 +41% 01 Jan 2016 31 Mar 2016 10-Q 05 May 2017 2017 Q1
Q4 2015 $13,840,000 $4,027,000 +$1,028,000 +34% 01 Oct 2015 31 Dec 2015 10-K 26 Feb 2018 2017 FY
Q3 2015 $12,812,000 $3,238,000 +$786,000 +32% 01 Jul 2015 30 Sep 2015 10-Q 04 Nov 2016 2016 Q3
Q2 2015 $12,026,000 $3,320,000 +$1,098,000 +49% 01 Apr 2015 30 Jun 2015 10-Q 04 Aug 2016 2016 Q2
Q1 2015 $10,928,000 $3,255,000 +$985,000 +43% 01 Jan 2015 31 Mar 2015 10-Q 05 May 2016 2016 Q1
Q4 2014 $9,943,000 $2,999,000 +$455,000 +18% 01 Oct 2014 31 Dec 2014 10-K 06 Mar 2017 2016 FY
Q3 2014 $9,488,000 $2,452,000 +$281,000 +13% 01 Jul 2014 30 Sep 2014 10-Q 05 Nov 2015 2015 Q3
Q2 2014 $9,207,000 $2,222,000 -$222,000 -9.1% 01 Apr 2014 30 Jun 2014 10-Q 05 Aug 2015 2015 Q2
Q1 2014 $9,429,000 $2,270,000 -$476,000 -17% 01 Jan 2014 31 Mar 2014 10-Q 05 May 2015 2015 Q1
Q4 2013 $9,905,000 $2,544,000 01 Oct 2013 31 Dec 2013 10-K 11 Mar 2016 2015 FY
Q3 2013 $2,171,000 -$217,000 -9.1% 01 Jul 2013 30 Sep 2013 10-Q 05 Nov 2014 2014 Q3
Q2 2013 $2,444,000 -$139,000 -5.4% 01 Apr 2013 30 Jun 2013 10-Q 05 Aug 2014 2014 Q2
Q1 2013 $2,746,000 01 Jan 2013 31 Mar 2013 10-Q 08 May 2014 2014 Q1
Q3 2012 $2,388,000 01 Jul 2012 30 Sep 2012 10-Q 12 Nov 2013 2013 Q3
Q2 2012 $2,583,000 01 Apr 2012 30 Jun 2012 10-Q 09 Aug 2013 2013 Q2

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $72,118,000 -$6,495,000 -8.3% 01 Jan 2023 31 Dec 2023 10-K 28 Feb 2024 2023 FY
2022 $78,613,000 -$2,115,000 -2.6% 01 Jan 2022 31 Dec 2022 10-K 28 Feb 2024 2023 FY
2021 $80,728,000 +$63,195,000 +360% 01 Jan 2021 31 Dec 2021 10-K 28 Feb 2024 2023 FY
2020 $17,533,000 +$1,132,000 +6.9% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
2019 $16,401,000 -$6,752,000 -29% 01 Jan 2019 31 Dec 2019 10-K 28 Feb 2022 2021 FY
2018 $23,153,000 +$2,801,000 +14% 01 Jan 2018 31 Dec 2018 10-K 26 Feb 2021 2020 FY
2017 $20,352,000 +$790,000 +4% 01 Jan 2017 31 Dec 2017 10-K 28 Feb 2020 2019 FY
2016 $19,562,000 +$5,722,000 +41% 01 Jan 2016 31 Dec 2016 10-K 26 Feb 2019 2018 FY
2015 $13,840,000 +$3,897,000 +39% 01 Jan 2015 31 Dec 2015 10-K 26 Feb 2018 2017 FY
2014 $9,943,000 +$38,000 +0.38% 01 Jan 2014 31 Dec 2014 10-K 06 Mar 2017 2016 FY
2013 $9,905,000 +$200,000 +2.1% 01 Jan 2013 31 Dec 2013 10-K 11 Mar 2016 2015 FY
2012 $9,705,000 -$2,679,000 -22% 01 Jan 2012 31 Dec 2012 10-K 12 Mar 2015 2014 FY
2011 $12,384,000 01 Jan 2011 31 Dec 2011 10-K 14 Mar 2014 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.